| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.34 | 1e-10 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.26 | 3e-10 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-06 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-06 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-05 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-05 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-05 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |